Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial.
To evaluate the effects of celecoxib combined with low-dose-rate brachytherapy on oncological outcomes and quality of life in prostate cancer.
Post hoc analysis of an open-label controlled randomized trial
Evaluation of long-term oncological outcomes
Assessment of quality of life indicators
Improvement in long-term oncological outcomes with the combination treatment
Enhanced quality of life reported among participants receiving celecoxib and brachytherapy
Abstract
Umin000003649.
问 AI
Like
Bookmark
Share
View Full Paper
问 AI
Like
Bookmark
Share
View Full Paper
Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial. | Synapse